<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37029655</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-4965</ISSN><JournalIssue CitedMedium="Internet"><Volume>112</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of biomedical materials research. Part A</Title><ISOAbbreviation>J Biomed Mater Res A</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 spike protein induces endothelial dysfunction in 3D engineered vascular networks.</ArticleTitle><Pagination><StartPage>524</StartPage><EndPage>533</EndPage><MedlinePgn>524-533</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jbm.a.37543</ELocationID><Abstract><AbstractText>With new daily discoveries about the long-term impacts of COVID-19, there is a clear need to develop in vitro models that can be used to better understand the pathogenicity and impact of COVID-19. Here, we demonstrate the utility of developing a model of endothelial dysfunction that utilizes human induced pluripotent stem cell-derived endothelial progenitors encapsulated in collagen hydrogels to study the effects of COVID-19 on the endothelium. These cells form capillary-like vasculature within 1 week after encapsulation and treating these cell-laden hydrogels with SARS-CoV-2 spike protein resulted in a significant decrease in the number of vessel-forming cells as well as vessel network connectivity quantified by our computational pipeline. This vascular dysfunction is a unique phenomenon observed upon treatment with SARS-CoV-2 SP and is not seen upon treatment with other coronaviruses, indicating that these effects were specific to SARS-CoV-2. We show that this vascular dysfunction is caused by an increase in inflammatory cytokines, associated with the COVID-19 cytokine storm, released from SARS-CoV-2 spike protein treated endothelial cells. Following treatment with the corticosteroid dexamethasone, we were able to prevent SARS-CoV-2 spike protein-induced endothelial dysfunction. Our results highlight the importance of understanding the interactions between SARS-CoV-2 spike protein and the endothelium and show that even in the absence of immune cells, the proposed 3D in vitro model for angiogenesis can reproduce COVID-19-induced endothelial dysfunction seen in clinical settings. This model represents a significant step in creating physiologically relevant disease models to further study the impact of long COVID and potentially identify mitigating therapeutics.</AbstractText><CopyrightInformation>&#xa9; 2023 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stern</LastName><ForeName>Brett</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-4336-6072</Identifier><AffiliationInfo><Affiliation>The University of Texas at Austin, Department of Biomedical Engineering, Austin, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monteleone</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>The University of Texas at Austin, Dell Medical School, Department of Internal Medicine, Austin, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Ascension Texas Cardiovascular, Austin, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoldan</LastName><ForeName>Janet</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The University of Texas at Austin, Department of Biomedical Engineering, Austin, Texas, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL157829</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 EB027812</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Mater Res A</MedlineTA><NlmUniqueID>101234237</NlmUniqueID><ISSNLinking>1549-3296</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020100">Hydrogels</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>bioRxiv. 2022 Oct 03:2022.10.01.510442. doi: 10.1101/2022.10.01.510442</RefSource><PMID Version="1">36238721</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020100" MajorTopicYN="N">Hydrogels</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3D in vitro models</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">angiogenesis</Keyword><Keyword MajorTopicYN="N">induced pluripotent stem cells</Keyword></KeywordList><CoiStatement>CONFLICT OF INTEREST STATEMENT. None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>8</Day><Hour>7</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37029655</ArticleId><ArticleId IdType="mid">NIHMS1911819</ArticleId><ArticleId IdType="pmc">PMC10560313</ArticleId><ArticleId IdType="doi">10.1002/jbm.a.37543</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Organization, W. H.
WHO coronavirus (COVID-19) dashboard j WHO coronavirus (COVID-19) dashboard with vaccination data, https://covid19.who.int/ (2023).</Citation></Reference><Reference><Citation>Libby P, Luscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. 2020;41:3038&#x2013;3044. doi:10.1093/eurheartj/ehaa623</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa623</ArticleId><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Klouda T, Hao Y, Kim H, et al. Interferon-alpha or -beta facilitates SARS-CoV-2 pulmonary vascular infection by inducing ACE2. Angiogenesis. 2021;25:225&#x2013;240. doi:10.1007/s10456-021-09823-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-021-09823-4</ArticleId><ArticleId IdType="pmc">PMC8554520</ArticleId><ArticleId IdType="pubmed">34714440</ArticleId></ArticleIdList></Reference><Reference><Citation>Acharya Y, Alameer A, Calpin G, Alkhattab M, Sultan S. A comprehensive review of vascular complications in COVID-19. J Thromb Thrombolysis. 2022;53:586&#x2013;593. doi:10.1007/s11239-021-02593-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-021-02593-2</ArticleId><ArticleId IdType="pmc">PMC8558544</ArticleId><ArticleId IdType="pubmed">34724155</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang Y, Chen T, Mui D, et al. Cardiovascular manifestations and treatment considerations in COVID-19. Heart. 2020;106:1132&#x2013;1141. doi: 10.1136/heartjnl-2020-317056</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2020-317056</ArticleId><ArticleId IdType="pmc">PMC7211105</ArticleId><ArticleId IdType="pubmed">32354800</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavriilaki E et al. Endothelial dysfunction in COVID-19: lessons learned from coronaviruses. Curr Hypertens Rep. 2020;22. doi:10.1007/s11906-020-01078-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-020-01078-6</ArticleId><ArticleId IdType="pmc">PMC7449866</ArticleId><ArticleId IdType="pubmed">32852642</ArticleId></ArticleIdList></Reference><Reference><Citation>Si L, Bai H, Rodas M, et al. A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics. Nat Biomed Eng. 2021;5:815&#x2013;829. doi:10.1038/s41551-021-00718-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41551-021-00718-9</ArticleId><ArticleId IdType="pmc">PMC8387338</ArticleId><ArticleId IdType="pubmed">33941899</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y, Eglen RM. Three-dimensional cell cultures in drug discovery and development. SLAS Discov. 2017;22:456&#x2013;472. doi:10.1177/1087057117696795</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1087057117696795</ArticleId><ArticleId IdType="pmc">PMC5448717</ArticleId><ArticleId IdType="pubmed">28520521</ArticleId></ArticleIdList></Reference><Reference><Citation>Langhans SA. Three-dimensional in vitro cell culture models in drug discovery and drug repositioning. Front Pharmacol. 2018;9:6. doi:10.3389/fphar.2018.00006</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00006</ArticleId><ArticleId IdType="pmc">PMC5787088</ArticleId><ArticleId IdType="pubmed">29410625</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Sievert D, Clark AE, et al. A human three-dimensional neural-perivascular &#x2018;assembloid&#x2019; promotes astrocytic development and enables modeling of SARS-CoV-2 neuropathology. Nat Med.2021;27:1600&#x2013;1606. doi:10.1038/s41591-021-01443-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01443-1</ArticleId><ArticleId IdType="pmc">PMC8601037</ArticleId><ArticleId IdType="pubmed">34244682</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteil V et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell. 2020; 181:905&#x2013;913.e907. doi:10.1016/j.cell.2020.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.004</ArticleId><ArticleId IdType="pmc">PMC7181998</ArticleId><ArticleId IdType="pubmed">32333836</ArticleId></ArticleIdList></Reference><Reference><Citation>Crosby CO, Valliappan D, Shu D, et al. Quantifying the vasculogenic potential of induced pluripotent stem cell-derived endothelial progenitors in collagen hydrogels. Tissue Eng Part A. 2019;25:746&#x2013;758. doi: 10.1089/ten.TEA.2018.0274</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ten.TEA.2018.0274</ArticleId><ArticleId IdType="pmc">PMC6535961</ArticleId><ArticleId IdType="pubmed">30618333</ArticleId></ArticleIdList></Reference><Reference><Citation>Crosby CO, Zoldan J. An In vitro 3D model and computational pipeline to quantify the vasculogenic potential of iPSC-derived endothelial progenitors. J Vis Exp. 2019. doi:10.3791/59342</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/59342</ArticleId><ArticleId IdType="pmc">PMC6938682</ArticleId><ArticleId IdType="pubmed">31132046</ArticleId></ArticleIdList></Reference><Reference><Citation>Crosby CO, Hillsley A, Kumar S, et al. Phototunable interpenetrating polymer network hydrogels to stimulate the vasculogenesis of stemcell-derived endothelial progenitors. Acta Biomater. 2021;122:133&#x2013;144. doi:10.1016/j.actbio.2020.12.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.actbio.2020.12.041</ArticleId><ArticleId IdType="pmc">PMC7983093</ArticleId><ArticleId IdType="pubmed">33359297</ArticleId></ArticleIdList></Reference><Reference><Citation>Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. 2010;123:4195&#x2013;4200. doi:10.1242/jcs.023820</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.023820</ArticleId><ArticleId IdType="pmc">PMC2995612</ArticleId><ArticleId IdType="pubmed">21123617</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian X, Bao X, al-Ahmad A, et al. Efficient differentiation of human pluripotent stem cells to endothelial progenitors via small-molecule activation of WNT signaling. Stem Cell Rep. 2014;3:804&#x2013;816. doi:10.1016/j.stemcr.2014.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2014.09.005</ArticleId><ArticleId IdType="pmc">PMC4235141</ArticleId><ArticleId IdType="pubmed">25418725</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezenah JR, Kong YP, Putnam AJ. Evaluating the potential of endothelial cells derived from human induced pluripotent stem cells to form microvascular networks in 3D cultures. Sci Rep. 2018;8:2671. doi:10.1038/s41598-018-20966-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20966-1</ArticleId><ArticleId IdType="pmc">PMC5805762</ArticleId><ArticleId IdType="pubmed">29422650</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265&#x2013;269. doi:10.1038/s41586-020-2008-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>van Boheemen S et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio. 2012;3. doi:10.1128/mBio.00473-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00473-12</ArticleId><ArticleId IdType="pmc">PMC3509437</ArticleId><ArticleId IdType="pubmed">23170002</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Yuan X, Chen H, Chaturvedi S, Braunstein EM, Brodsky RA. Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition. Blood. 2020; 136:2080&#x2013;2089. doi:10.1182/blood.2020008248</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020008248</ArticleId><ArticleId IdType="pmc">PMC7596849</ArticleId><ArticleId IdType="pubmed">32877502</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke Z, Oton J, Qu K, et al. Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature. 2020;588:498&#x2013;502. doi:10.1038/s41586-020-2665-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2665-2</ArticleId><ArticleId IdType="pmc">PMC7116492</ArticleId><ArticleId IdType="pubmed">32805734</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhavnani D, James ER, Johnson KE, et al. SARS-CoV-2 viral load is associated with risk of transmission to household and community contacts. BMC Infect Dis. 2022;22:672. doi:10.1186/s12879-022-07663-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07663-1</ArticleId><ArticleId IdType="pmc">PMC9354300</ArticleId><ArticleId IdType="pubmed">35931971</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zhang L, Sang L, et al. Kinetics of viral load and antibody response in relation to COVID-19 severity. J Clin Invest. 2020;130: 5235&#x2013;5244. doi:10.1172/JCI138759</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI138759</ArticleId><ArticleId IdType="pmc">PMC7524490</ArticleId><ArticleId IdType="pubmed">32634129</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan RWY, Chan MCW, Agnihothram S, et al. Tropism of and innate immune responses to the novel human Betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J Virol. 2013;87: 6604&#x2013;6614. doi:10.1128/JVI.00009-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00009-13</ArticleId><ArticleId IdType="pmc">PMC3676115</ArticleId><ArticleId IdType="pubmed">23552422</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Z, Li X, Fan RLY, et al. A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4. Stem Cell Rep. 2022;17:538&#x2013;555. doi:10.1016/j.stemcr.2022.01.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2022.01.015</ArticleId><ArticleId IdType="pmc">PMC8851885</ArticleId><ArticleId IdType="pubmed">35180397</ArticleId></ArticleIdList></Reference><Reference><Citation>Mubarak A, Alturaiki W, Hemida MG. Middle East respiratory syndrome coronavirus (MERS-CoV): infection, immunological response, and vaccine development. J Immunol Res. 2019;2019(6491738):1&#x2013;11. doi:10.1155/2019/6491738</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/6491738</ArticleId><ArticleId IdType="pmc">PMC6476043</ArticleId><ArticleId IdType="pubmed">31089478</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care. 2020;24:353. doi:10.1186/s13054-020-03062-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03062-7</ArticleId><ArticleId IdType="pmc">PMC7296907</ArticleId><ArticleId IdType="pubmed">32546188</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin G, Finger E, Gutierrez-Ramos JC. Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissues. Eur J Immunol. 1995;25:1508&#x2013;1516. doi:10.1002/eji.1830250606</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830250606</ArticleId><ArticleId IdType="pubmed">7542195</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel J, Seppanen EJ, Rodero MP, et al. Functional definition of progenitors versus mature endothelial cells reveals key SoxF-dependent differentiation process. Circulation. 2017;135:786&#x2013;805. doi:10.1161/CIRCULATIONAHA.116.024754</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.116.024754</ArticleId><ArticleId IdType="pubmed">27899395</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen IY, Chang SC, Wu HY, et al. Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway. J Virol. 2010;84:7703&#x2013;7712. doi: 10.1128/JVI.02560-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02560-09</ArticleId><ArticleId IdType="pmc">PMC2897593</ArticleId><ArticleId IdType="pubmed">20484496</ArticleId></ArticleIdList></Reference><Reference><Citation>Utgaard JO, Jahnsen FL, Bakka A, Brandtzaeg P, Haraldsen G. Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells. J Exp Med. 1998;188:1751&#x2013;1756. doi: 10.1084/jem.188.9.1751</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.188.9.1751</ArticleId><ArticleId IdType="pmc">PMC2212514</ArticleId><ArticleId IdType="pubmed">9802986</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyake M, Goodison S, Urquidi V, Gomes Giacoia E, Rosser CJ. Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways. Lab Invest. 2013;93:768&#x2013;778. doi:10.1038/labinvest.2013.71</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2013.71</ArticleId><ArticleId IdType="pubmed">23732813</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z-S, Shu T, Kang L, et al. Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients. Signal Transduct Target Ther. 2020;5:100. doi:10.1038/s41392-020-0211-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-0211-1</ArticleId><ArticleId IdType="pmc">PMC7303571</ArticleId><ArticleId IdType="pubmed">32561706</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Li J, Gao M, et al. Interleukin-8 as a biomarker for disease prognosis of coronavirus Disease-2019 patients. Front Immunol. 2020;11: 602395. doi:10.3389/fimmu.2020.602395</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.602395</ArticleId><ArticleId IdType="pmc">PMC7820901</ArticleId><ArticleId IdType="pubmed">33488599</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing X, Xu M, Song D, et al. Association between inflammatory cytokines and anti-SARS-CoV-2 antibodies in hospitalized patients with COVID-19. Immun Ageing. 2022;19:12. doi:10.1186/s12979-022-00271-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-022-00271-2</ArticleId><ArticleId IdType="pmc">PMC8897556</ArticleId><ArticleId IdType="pubmed">35248063</ArticleId></ArticleIdList></Reference><Reference><Citation>Group RC et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384:693&#x2013;704. doi:10.1056/NEJMoa2021436</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberleithner H, Riethm&#xfc;ller C, Ludwig T, et al. Differential action of steroid hormones on human endothelium. J Cell Sci. 2006;119:1926&#x2013;1932. doi:10.1242/jcs.02886</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.02886</ArticleId><ArticleId IdType="pubmed">16636077</ArticleId></ArticleIdList></Reference><Reference><Citation>Weijtens O, Schoemaker RC, Cohen AF, et al. Dexamethasone concentration in vitreous and serum after oral administration. Am J Ophthalmol. 1998;125:673&#x2013;679. doi:10.1016/s0002-9394(98)00003-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-9394(98)00003-8</ArticleId><ArticleId IdType="pubmed">9625551</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X, Zhang S, Gou J, et al. Spike-mediated ACE2 down-regulation was involved in the pathogenesis of SARS-CoV-2 infection. J Infect. 2022;85:418&#x2013;427. doi:10.1016/j.jinf.2022.06.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.06.030</ArticleId><ArticleId IdType="pmc">PMC9250808</ArticleId><ArticleId IdType="pubmed">35793758</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, van Esch BCAM, Henricks PAJ, Garssen J, Folkerts G. Time and concentration dependent effects of short chain fatty acids on lipopolysaccharide- or tumor necrosis factor &#x3b1;-induced endothelial activation. Front Pharmacol. 2018;9. doi:10.3389/fphar.2018.00233</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00233</ArticleId><ArticleId IdType="pmc">PMC5867315</ArticleId><ArticleId IdType="pubmed">29615908</ArticleId></ArticleIdList></Reference><Reference><Citation>Su H, Lei C-T, Zhang C. Interleukin-6 signaling pathway and its role in kidney disease: an update. Front Immunol. 2017;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5399081</ArticleId><ArticleId IdType="pubmed">28484449</ArticleId></ArticleIdList></Reference><Reference><Citation>Bickel M The role of interleukin-8 in inflammation and mechanisms of regulation. J Periodontol. 1993;64:456&#x2013;460.</Citation><ArticleIdList><ArticleId IdType="pubmed">8315568</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawant KV, Poluri KM, Dutta AK, et al. Chemokine CXCL1 mediated neutrophil recruitment: role of glycosaminoglycan interactions. Sci Rep. 2016;6:33123. doi:10.1038/srep33123</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep33123</ArticleId><ArticleId IdType="pmc">PMC5021969</ArticleId><ArticleId IdType="pubmed">27625115</ArticleId></ArticleIdList></Reference><Reference><Citation>el Zaoui I, Behar-Cohen F, Torriglia A. Glucocorticoids exert direct toxicity on microvasculature: analysis of cell death mechanisms. Toxicol Sci. 2014;143:441&#x2013;453. doi:10.1093/toxsci/kfu243</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfu243</ArticleId><ArticleId IdType="pubmed">25447644</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>